Insider Activity of Reardon Andrew
According to the SEC Form 4 filings, Reardon Andrew, being in a position of
- CLO & Secretary at Ligand Pharmaceuticals Incorporated,оver the last 12 months, has bought 0 shares, and sold 40000 shares for $10.29M,over all time since 2023-03-24, has bought 0 shares, and sold 55800 shares for $11.72M.
Biography of Reardon Andrew
No biography is available at this moment.